Long-Term Functional Outcomes, Safety, and Micro-Dystrophin Expression Following Delandistrogene Moxeparvovec Treatment in DMD: EMBARK 2-Year Results

Category Primary study
ConferenceNEP 50th Annual Meeting of the Society for Neuropediatrics, 2025
Year 2025
This article has no abstract
Epistemonikos ID: 3dc7a8450f91cc8144437791e527b74a591847a3
First added on: Jun 15, 2026